| Literature DB >> 16961581 |
G Notheis1, L Tarani, F Costantino, A Jansson, J Rosenecker, D Friederici, B H Belohradsky, D Reinhardt, R Seger, D V Schweinitz, Uwe Wintergerst.
Abstract
Invasive fungal infections are usually associated with immunocompromised states About 40-60% of these patients are refractory to standard antifungal therapy We describe the effect of posaconazole in the treatment of a 12 years-old girl with uncontrolled diabetes mellitus with life-threatening cerebral mucor mycosis and a 4 year old girl boy with chronic granulomatous disease presenting with invasive Aspergillus nidulans infection.Entities:
Mesh：
Substances：
Year: 2006 PMID： 16961581 DOI： 10.1111/j.1439-0507.2006.01301.x
Source DB: PubMed Journal: Mycoses ISSN： 0933-7407 Impact factor: 4.377